Post-menopausal Osteoporosis Market Report 2030 | Post-menopausal Osteoporosis Market Research Report 2030

1. Post-Menopausal Osteoporosis Market Osteoporosis is a common ailment seen in postmenopausal women, resulting in fragile and weak bones highly susceptible to fractures of hips, spine and wrist. One in three women over age of 50 years will develop the disease during their lifetime. Loss of 20% bone mass in 5 to 7 years following menopause is seen. Osteoporosis can be fatal and more women die of hip fracture, than from cancer of ovaries, cervix and uterus combined. It is a silent disease, because bone loss occurs without symptoms. DelveInsight's "Post-Menopausal Osteoporosis - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Post-Menopausal Osteoporosis, historical and forecasted epidemiology as well as the Post-Menopausal Osteoporosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Post-Menopausal Osteoporosis market report provides current treatment practices, emerging drugs, Post-Menopausal Osteoporosis market share of the individual therapies, current and forecasted Post-Menopausal Osteoporosis market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Post-Menopausal Osteoporosis treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market. Geography Covered The United States EU5 (Germany, France, Italy, Spain, and the United Kingdom) Japan    Study Period:2017-2030 Request for sample pages: https://www.delveinsight.com/sample-request/post- menopausal-osteoporosis-market Post-Menopausal Osteoporosis Disease Understanding and Treatment Algorithm The prevalence of osteoporosis is continuing to escalate with the increasingly elderly population. The major complication of osteoporosis is an increase in fragility fractures leading to morbidity, mortality, and decreased quality of life. The DelveInsight Post-Menopausal Osteoporosis market report gives a thorough understanding of the Post-Menopausal Osteoporosis by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment. Diagnosis This segment of the report covers the detailed diagnostic methods or tests for Post- Menopausal Osteoporosis.

2. Treatment It covers the details of conventional and current medical therapies available in the Post- Menopausal Osteoporosis market for the treatment of the condition. It also provides Post- Menopausal Osteoporosis treatment algorithms and guidelines in the United States, Europe, and Japan. Post-Menopausal Osteoporosis Epidemiology Due to its prevalence worldwide, osteoporosis is considered a serious public health concern. Currently it is estimated that over 200 million people worldwide suffer from this disease. Approximately 30% of all postmenopausal women have osteoporosis in the United States and in Europe. At least 40% of these women and 15-30% of men will sustain one or more fragility fractures in their remaining lifetime. Ageing of populations worldwide will be responsible for a major increase in the incidence of osteoporosis in postmenopausal women. Using the WHO criteria, 30% of postmenopausal Caucasian women have osteoporosis at the hip, lumbar spine or distal forearm. The Post-Menopausal Osteoporosis epidemiology division provide insights about historical and current Post-Menopausal Osteoporosispatient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken. Key Findings The disease epidemiology covered in the report provides historical as well as forecasted Post-Menopausal Osteoporosisepidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030. Country Wise- Post-Menopausal Osteoporosis Epidemiology The epidemiology segment also provides the Post-Menopausal Osteoporosis epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. Download sample pages: https://www.delveinsight.com/sample-request/post- menopausal-osteoporosis-market Post-Menopausal Osteoporosis Market Outlook Postmenopausal osteoporosis affects millions of women, being estrogen deficiency the key factor in the pathogenesis of involutional osteoporosis. Different treatments for osteoporosis are available. The various options are aimed to maintain bone health and decrease the risk of fractures. The majority of these drugs are antiresorptive agents, i.e., drugs that lower bone turnover, inhibiting osteoclastic bone resorption. Bisphosphonates are first-line therapy for

3. patients with established osteoporosis at high risk of fracture. The monoclonal antibody to RANKL, named denosumab, administered as a 60-mg subcutaneous injection every 6 months, is a valuable option for the treatment of postmenopausal osteoporosis in women at increased or high risk of fractures, who are unable to take other osteoporosis treatments. Other approved drugs include Tymlos by Radius Health and Livial by Organon. Tymlos is the first new anabolic (bone building) agent for postmenopausal women with osteoporosis in the United States in nearly 15 years. The Post-Menopausal Osteoporosis market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Post-Menopausal Osteoporosismarkettrends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. This segment gives a thorough detail of Post-Menopausal Osteoporosismarket trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight. According to DelveInsight, Post-Menopausal Osteoporosismarket in 7MM is expected to change in the study period 2017-2030. Download full report: https://www.delveinsight.com/report-store/post-menopausal- osteoporosis-market View pipeline insights of the report @https://www.delveinsight.com/report-store/post- menopausal-osteoporosis-pipeline-insight Click here and access to our free sample pages: Request for sample pages: https://www.delveinsight.com/sample-request/post-menopausal-osteoporosis-market